Cargando…

Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes

Paclitaxel (PTX) is a hydrophobic small-molecule cancer drug that loads into the membrane (tail) region of lipid carriers such as liposomes and micelles. The development of improved lipid-based carriers of PTX is an important objective to generate chemotherapeutics with fewer side effects. The lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffes, Victoria, MacDonald, Scott, Crowe, John, Murali, Meena, Ewert, Kai K., Li, Youli, Safinya, Cyrus R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614943/
https://www.ncbi.nlm.nih.gov/pubmed/37905081
http://dx.doi.org/10.1101/2023.10.18.563006
_version_ 1785129124050763776
author Steffes, Victoria
MacDonald, Scott
Crowe, John
Murali, Meena
Ewert, Kai K.
Li, Youli
Safinya, Cyrus R.
author_facet Steffes, Victoria
MacDonald, Scott
Crowe, John
Murali, Meena
Ewert, Kai K.
Li, Youli
Safinya, Cyrus R.
author_sort Steffes, Victoria
collection PubMed
description Paclitaxel (PTX) is a hydrophobic small-molecule cancer drug that loads into the membrane (tail) region of lipid carriers such as liposomes and micelles. The development of improved lipid-based carriers of PTX is an important objective to generate chemotherapeutics with fewer side effects. The lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and glyceryl monooleate (GMO) show propensity for fusion with other lipid membranes, which has led to their use in lipid vectors of nucleic acids. We hypothesized that DOPE and GMO could enhance PTX delivery to cells through a similar membrane fusion mechanism. As an important measure of drug carrier performance, we evaluated PTX solubility in cationic liposomes containing GMO or DOPE. Solubility was determined by time-dependent kinetic phase diagrams generated from direct observations of PTX crystal formation using differential-interference-contrast optical microscopy. Remarkably, PTX was much less soluble in these liposomes than in control cationic liposomes containing univalent cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC), which are not fusogenic. In particular, PTX was not substantially soluble in GMO-based cationic liposomes. The fusogenicity of DOPE and GMO is related to the negative spontaneous curvature of membranes containing these lipids, which drives formation of nonlamellar self-assembled phases (inverted hexagonal or gyroid cubic). We used synchrotron small-angle x-ray scattering to determine whether PTX solubility is governed by lipid membrane structure (condensed with DNA in pellet form) or by local intermolecular interactions. The results suggest that local intermolecular interactions are of greater importance and that the negative spontaneous curvature-inducing lipids DOPE and GMO are not suitable components of lipid carriers for PTX delivery regardless of carrier structure.
format Online
Article
Text
id pubmed-10614943
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-106149432023-10-31 Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes Steffes, Victoria MacDonald, Scott Crowe, John Murali, Meena Ewert, Kai K. Li, Youli Safinya, Cyrus R. bioRxiv Article Paclitaxel (PTX) is a hydrophobic small-molecule cancer drug that loads into the membrane (tail) region of lipid carriers such as liposomes and micelles. The development of improved lipid-based carriers of PTX is an important objective to generate chemotherapeutics with fewer side effects. The lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and glyceryl monooleate (GMO) show propensity for fusion with other lipid membranes, which has led to their use in lipid vectors of nucleic acids. We hypothesized that DOPE and GMO could enhance PTX delivery to cells through a similar membrane fusion mechanism. As an important measure of drug carrier performance, we evaluated PTX solubility in cationic liposomes containing GMO or DOPE. Solubility was determined by time-dependent kinetic phase diagrams generated from direct observations of PTX crystal formation using differential-interference-contrast optical microscopy. Remarkably, PTX was much less soluble in these liposomes than in control cationic liposomes containing univalent cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC), which are not fusogenic. In particular, PTX was not substantially soluble in GMO-based cationic liposomes. The fusogenicity of DOPE and GMO is related to the negative spontaneous curvature of membranes containing these lipids, which drives formation of nonlamellar self-assembled phases (inverted hexagonal or gyroid cubic). We used synchrotron small-angle x-ray scattering to determine whether PTX solubility is governed by lipid membrane structure (condensed with DNA in pellet form) or by local intermolecular interactions. The results suggest that local intermolecular interactions are of greater importance and that the negative spontaneous curvature-inducing lipids DOPE and GMO are not suitable components of lipid carriers for PTX delivery regardless of carrier structure. Cold Spring Harbor Laboratory 2023-10-21 /pmc/articles/PMC10614943/ /pubmed/37905081 http://dx.doi.org/10.1101/2023.10.18.563006 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Steffes, Victoria
MacDonald, Scott
Crowe, John
Murali, Meena
Ewert, Kai K.
Li, Youli
Safinya, Cyrus R.
Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
title Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
title_full Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
title_fullStr Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
title_full_unstemmed Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
title_short Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
title_sort lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614943/
https://www.ncbi.nlm.nih.gov/pubmed/37905081
http://dx.doi.org/10.1101/2023.10.18.563006
work_keys_str_mv AT steffesvictoria lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes
AT macdonaldscott lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes
AT crowejohn lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes
AT muralimeena lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes
AT ewertkaik lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes
AT liyouli lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes
AT safinyacyrusr lipidswithnegativespontaneouscurvaturedecreasethesolubilityofthecancerdrugpaclitaxelinliposomes